Pages that link to "Q42816610"

The following pages link to Establishment of five human myeloma cell lines (Q42816610):

Displaying 40 items.

• (3)D [corrected] quantification of tumor vasculature in lymphoma xenografts in NOD/SCID mice allows to detect differences among vascular-targeted therapies (Q28488869) (← links)
• Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma (Q28534603) (← links)
• A novel phthalimide derivative, TC11, has preclinical effects on high-risk myeloma cells and osteoclasts (Q28543087) (← links)
• Frequent inactivation of the cyclin-dependent kinase inhibitor p18 by homozygous deletion in multiple myeloma cell lines: ectopic p18 expression inhibits growth and induces apoptosis (Q30308687) (← links)
• Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia (Q33998315) (← links)
• Tumour cell generation of inducible regulatory T-cells in multiple myeloma is contact-dependent and antigen-presenting cell-independent (Q34292398) (← links)
• ZFP36L1 negatively regulates plasmacytoid differentiation of BCL1 cells by targeting BLIMP1 mRNA. (Q34533271) (← links)
• PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells (Q34543759) (← links)
• Molecular basis of differential sensitivity of myeloma cells to clinically relevant bolus treatment with bortezomib (Q34608271) (← links)
• Bortezomib reduces the tumorigenicity of multiple myeloma via downregulation of upregulated targets in clonogenic side population cells (Q34612981) (← links)
• The natural pesticide dihydrorotenone induces human plasma cell apoptosis by triggering endoplasmic reticulum stress and activating p38 signaling pathway. (Q34904775) (← links)
• Dual targeting of the thioredoxin and glutathione antioxidant systems in malignant B cells: a novel synergistic therapeutic approach (Q35072963) (← links)
• Identification of agents that promote endoplasmic reticulum stress using an assay that monitors luciferase secretion (Q35076504) (← links)
• Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma (Q35938169) (← links)
• Multiple myeloma cells expressing low levels of CD138 have an immature phenotype and reduced sensitivity to lenalidomide (Q36640589) (← links)
• Identification of an ABCB1 (P-glycoprotein)-positive carfilzomib-resistant myeloma subpopulation by the pluripotent stem cell fluorescent dye CDy1 (Q36717999) (← links)
• Antimalarial activity of axidjiferosides, new β-galactosylceramides from the African sponge Axinyssa djiferi (Q36994245) (← links)
• An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignancies (Q37029273) (← links)
• Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma (Q37148117) (← links)
• Activation of the endoplasmic reticulum stress-associated transcription factor x box-binding protein-1 occurs in a subset of normal germinal-center B cells and in aggressive B-cell lymphomas with prognostic implications (Q37197408) (← links)
• Fibroblast growth factor receptor 3 interacts with and activates TGFβ-activated kinase 1 tyrosine phosphorylation and NFκB signaling in multiple myeloma and bladder cancer (Q37510049) (← links)
• Gene integrated set profile analysis: a context-based approach for inferring biological endpoints (Q38798005) (← links)
• Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells (Q38926469) (← links)
• Cytotoxicity on Human Cancer Cells of Ophidiacerebrosides Isolated from the African Starfish Narcissia canariensis (Q39588314) (← links)
• Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells (Q40388164) (← links)
• Accelerated proliferation of myeloma cells by interleukin-6 cooperating with fibroblast growth factor receptor 3-mediated signals (Q40412879) (← links)
• Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations (Q40795919) (← links)
• Human myeloma cell apoptosis induced by interferon-alpha (Q40992802) (← links)
• Analysis of methylation in the c-MYC gene in five human myeloma cell lines (Q41696394) (← links)
• Expression and in vitro modification of parathyroid hormone-related protein (PTHrP) and PTH/PTHrP-receptor in human myeloma cells (Q43621671) (← links)
• Increased susceptibility to apoptosis in CD45( ) myeloma cells accompanied by the increased expression of VDAC1. (Q51330907) (← links)
• KMM-1 (Q54900126) (← links)
• KMS-11 (Q54900162) (← links)
• KMS-12-BM (Q54900168) (← links)
• KMS-12-PE (Q54900169) (← links)
• KMS-5 (Q54900185) (← links)
• DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling (Q60922662) (← links)
• Murine T cell leukemia line in suspension culture (Q67970465) (← links)
• Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis (Q89983797) (← links)
• The long non-coding RNA CRNDE regulates growth of multiple myeloma cells via an effect on IL6 signalling (Q98906816) (← links)